Your browser doesn't support javascript.
loading
ALK7 Signaling Manifests a Homeostatic Tissue Barrier That Is Abrogated during Tumorigenesis and Metastasis.
Michael, Iacovos P; Saghafinia, Sadegh; Tichet, Mélanie; Zangger, Nadine; Marinoni, Ilaria; Perren, Aurel; Hanahan, Douglas.
Afiliação
  • Michael IP; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne 1015, Switzerland.
  • Saghafinia S; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne 1015, Switzerland.
  • Tichet M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne 1015, Switzerland.
  • Zangger N; Bioinformatics Core Facility, Swiss Institute of Bioinformatics (SIB), Lausanne 1015, Switzerland.
  • Marinoni I; Institute of Pathology, University of Bern, Bern 3010, Switzerland.
  • Perren A; Institute of Pathology, University of Bern, Bern 3010, Switzerland.
  • Hanahan D; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne 1015, Switzerland. Electronic address: douglas.hanahan@epfl.ch.
Dev Cell ; 49(3): 409-424.e6, 2019 05 06.
Article em En | MEDLINE | ID: mdl-31063757

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativinas / Receptores de Ativinas Tipo I / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ativinas / Receptores de Ativinas Tipo I / Neoplasias Idioma: En Ano de publicação: 2019 Tipo de documento: Article